• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis. Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January-February 2020

tetano

Editor, Senior Moderator
Emerg Infect Dis. 2020 Mar 13;26(6). doi: 10.3201/eid2606.200233. [Epub ahead of print]
Estimating Risk for Death from 2019 Novel Coronavirus Disease, China, January-February 2020.


Mizumoto K, Chowell G.

Abstract

Since December 2019, when the first case of 2019 novel coronavirus disease (COVID-19) was identified in the city of Wuhan in the Hubei Province of China, the epidemic has generated tens of thousands of cases throughout China. As of February 28, 2020, the cumulative number of reported deaths in China was 2,858. We estimated the time-delay adjusted risk for death from COVID-19 in Wuhan, as well as for China excluding Wuhan, to assess the severity of the epidemic in the country. Our estimates of the risk for death in Wuhan reached values as high as 12% in the epicenter of the epidemic and ≈1% in other, more mildly affected areas. The elevated death risk estimates are probably associated with a breakdown of the healthcare system, indicating that enhanced public health interventions, including social distancing and movement restrictions, should be implemented to bring the COVID-19 epidemic under control.



KEYWORDS:

2019 novel coronavirus disease; CFR; COVID-19; China; Hubei; SARS-CoV-2; Wuhan; case-fatality ratio; coronavirus; death; mortality; outbreak; respiratory diseases; risk; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses


PMID:32168464DOI:10.3201/eid2606.200233
Free full text
 
Back
Top Bottom